New Combo therapy, nanoparticle delivery system show promise for pancreatic cancer
Monday, June 8, 2020 - 10:20
in Health & Medicine
A new multi-drug combination therapy for pancreatic cancer is inching toward clinical trials in humans. The drug compound, called SapC-DOPS, combines chemotherapy with targeted therapy and can kill cancer cells.